ArticleScientific reports2025
Prevalence and associated factors of thrombocytopenia among neonates in Northwest Amhara region comprehensive specialized hospitals, Ethiopia: a cross sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombocytopenia is a common hematologic concern in neonates and can lead to severe complications, including significant bleeding particularly intracranial hemorrhage. This risk is especially critical in preterm infants or those with other coexisting conditions. While neonatal thrombocytopenia has been studied in some countries, there is limited data and understanding about its prevalence, and associated factors in resource-limited countries especially in Ethiopia. So this study aimed to assess the prevalence and factors associated with thrombocytopenia among neonates admitted to the neonatal intensive care unit of Northwest Amhara Region Comprehensive Specialized Hospitals in Northwest Ethiopia, 2022. Institution-based cross-sectional study design was conducted from October 05 to November 03, 2022, and a systematic random sampling technique was used to select 423 study participants. Data were collected by interviewing mothers and reviewing neonates' medical records. Data were entered into Epi-Data version 4.6.0 and exported to STATA version 14 for analysis. Both bivariable and multivariable logistic regression models were used for analysis. P-value of less than 0.05 and odds ratio with 95% CI was used to declare the presence of association. A total of 415 neonate-mother pairs were involved with a response rate of 98.1%. The prevalence of thrombocytopenia among neonates admitted to the neonatal intensive care unit Is found to be 26.02%; [95% CI (22.01-30.48%)]. In the multivariable analysis severe pre-eclampsia (AOR = 2.84 95% CI 1.29-6.27), prolonged rupture of membrane (AOR = 2.85 95% CI 1.21-6.72), neonatal sepsis (AOR = 6.50 95% CI 3.58-11.79), perinatal asphyxia (AOR = 4.15 95% CI 1.97-8.76), and necrotizing enterocolitis (AOR = 3.71 95% CI 1.68-8.19) were significant factors to thrombocytopenia. To decrease the occurrence of neonatal thrombocytopenia better to give special attention and priority to neonates diagnosed with sepsis, perinatal asphyxia, necrotizing enterocolitis, and mothers who had prolonged rupture of membrane or severe pre-eclampsia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.